Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hoang

Showing results (251-260 of 349) with videos related to

Pageof 35
Sort By:
AJR. American Journal of Roentgenology|April 25, 2012
Organ-based dose current modulation and thyroid shields: techniques of radiation dose reduction for neck CTJenny K Hoang, Terry T Yoshizumi, Kingshuk Roy Choudhury, et al.
Annals of Neurology|December 10, 1999
Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression FrançaiseX P Zhou, M Sanson, K Hoang-Xuan, et al.
British Journal of Cancer|May 26, 2011
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopyR Guillevin, C Menuel, S Taillibert, et al.
Revue Neurologique|June 21, 2008
[Neurological damage of brain tumor therapy]D Ricard, T De Greslan, C Soussain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphomaC Soussain, F Suzan, K Hoang-Xuan, et al.
Neurology|October 10, 2001
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progressionK Hoang-Xuan, J He, S Huguet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2005
Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiformeM Barrié, C Couprie, H Dufour, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 11, 2019
Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastomaL Lahmi, A Idbaih, E Rivin Del Campo, et al.
Thyroid : Official Journal of the American Thyroid Association|March 18, 2015
Misinterpretation of the American College of Radiology white paper on managing incidental thyroid nodulesJenny K Hoang, Jill E Langer, William D Middleton, et al.
Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.
Pageof 35

Showing results (251-260 of 349) with videos related to

Sort By:
Pageof 35
AJR. American Journal of Roentgenology|April 25, 2012
Organ-based dose current modulation and thyroid shields: techniques of radiation dose reduction for neck CTJenny K Hoang, Terry T Yoshizumi, Kingshuk Roy Choudhury, et al.
Annals of Neurology|December 10, 1999
Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression FrançaiseX P Zhou, M Sanson, K Hoang-Xuan, et al.
British Journal of Cancer|May 26, 2011
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopyR Guillevin, C Menuel, S Taillibert, et al.
Revue Neurologique|June 21, 2008
[Neurological damage of brain tumor therapy]D Ricard, T De Greslan, C Soussain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphomaC Soussain, F Suzan, K Hoang-Xuan, et al.
Neurology|October 10, 2001
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progressionK Hoang-Xuan, J He, S Huguet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2005
Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiformeM Barrié, C Couprie, H Dufour, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 11, 2019
Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastomaL Lahmi, A Idbaih, E Rivin Del Campo, et al.
Thyroid : Official Journal of the American Thyroid Association|March 18, 2015
Misinterpretation of the American College of Radiology white paper on managing incidental thyroid nodulesJenny K Hoang, Jill E Langer, William D Middleton, et al.
Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.
Pageof 35